Fischer Imaging Announces Initial Shipments of Cedara-based SenoView(TM) Plus Softcopy Workstations; Installations at Leading Hospitals Across North America TORONTO, Sept. 30 /PRNewswire-FirstCall/ -- Fischer Imaging Corporation (FIMG:PK) today announced that it has begun initial shipments of a new, leading edge digital mammography workstation, the result of its collaboration with Cedara Software Corp. (TSX:CDE/NASDAQ:CDSW). The softcopy workstation, named SenoView Plus, is integrated with Fischer's SenoScan(R) digital mammography system to provide radiologists with powerful new capabilities for diagnosing breast cancer. Hospitals that have installed or are about to install the workstations include: Mt. Sinai Hospital, Marvelle Koffler Breast Centre, Toronto; City Hospital, Martinsburg, West Virginia; and Sansum Santa Barbara Medical Foundation Clinic, Santa Barbara, CA. The SenoView Plus workstation will allow radiologists to compare SenoScan digital mammography images and competitive FFDM images with multi-modality images, such as ultrasound and MRIs. The workstation's PACS-like design lends itself to reading studies from all modalities with speed. The net result is the ability to deliver optimal workflow and reading efficiency compared with traditional film screen mammography systems with the added versatility of a PACS review station. Fischer and Cedara teams were able to rapidly integrate their respective systems as a result of the open architecture of the SenoScan imaging platform. By producing images in an industry-standard DICOM format SenoScan is open to leading current and future complementary technologies assuring customers maximum choice and flexibility. "Our open architecture assures customers not only the freedom of choice they desire, but the opportunity to achieve the highest possible performance from their mammography operations," said Harris Ravine, Fischer Imaging president and CEO. "Cedara brings powerful, specialized multi-modality; digital workstation capabilities that will help Fischer achieve its goal of providing the best total solution. I am pleased by how rapidly our respective teams were able to complete and assure the product offering and get it into our customers' hands," said Ravine. For more information about Cedara, visit the Cedara website at http://www.cedara.com/ or contact: Michelle Pommells, Cedara Software Corp., (905) 672-2100 ext. 2356. Email: . For investor-related inquiries, contact: Brian Pedlar, Chief Financial Officer (905) 672-2100 ext. 2015 Email: About Fischer Imaging Fischer Imaging Corporation designs, manufactures and markets medical imaging systems for the screening and diagnosis of disease. The company focuses on women's health, particularly the diagnosis and screening of breast cancer through the application of innovative digital imaging technologies. Fischer Imaging began producing general-purpose x-ray imaging systems in 1910 and is the oldest manufacturer of x-ray imaging devices in the United States. For more information, visit http://www.fischerimaging.com/. Contact: Michael Klatman, Resonant Communications (for Fischer Imaging) 303-581-0509 About Cedara Software: Cedara Software Corp. is a leading independent provider of medical technologies for many of the world's leading medical device and healthcare information technology companies. Cedara software is deployed in hospitals and clinics worldwide - approximately 20,000 medical imaging systems and 4,600 Picture Archiving and Communications System (PACS) workstations have been licensed to date. Cedara is enabling the future of the healthcare industry with new innovative approaches to workflow, data and image management, integration, the web, software components and professional services. The Company's medical imaging solutions are used in all aspects of clinical workflow including the capture of patient digital images; the sharing and archiving of images; sophisticated tools to analyze and manipulate images; and even the use of imaging in surgery. Cedara is unique in that it has expertise and technologies that span all the major digital imaging modalities including angiography, computed tomography (CT), echo-cardiology, digital X-ray, fluoroscopy, mammography, magnetic resonance imaging (MRI), nuclear medicine, positron emission tomography (PET) and ultrasound. Certain statements contained in this news release are forward-looking within the meaning of securities laws and are based on current expectations that are subject to a number of assumptions, uncertainties and risks, and there are actual results may differ materially from what is currently expected. These assumptions, uncertainties and risks include, but are not limited to: the management of the growth of the Company, dependence on key personnel of the Company, competitive pressures (including price competition), changes in market activity, risks associated with international operations, the development of new products and services, the enhancement of existing products and services, the introduction of competing products having technological and/or other advantages, the dependence on key customers, regulatory changes to the health care industry, seasonality, economic and political conditions and adequate protection of the proprietary interests of the Company. Further information about these risks and uncertainties can be found in the continuous disclosure documents filed from time to time by Cedara with the securities regulatory authorities, which documents are available at http://www.sedar.com/. All trademarks appearing in this release are the property of Cedara Software Corp. DATASOURCE: Cedara Software Corp. CONTACT: Michelle Pommells, Director Product Communications, Cedara Software Corp., (905) 672-2100 ext. 2356, ; To request a free copy of this organization's annual report, please go to http://www.newswire.ca/ and click on reports@cnw.

Copyright